🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 11

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 11 of 20
SaraMom3
Member
456
2,345
Aug 2024
Ohio
Nov 29, 2024 at 5:04 AM#51

A narrower follow-up, since the general answer is now clear:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Nov 29, 2024 at 9:04 AM
21 19BethLabQueen, ChrisMacros, KetoKyle and 18 others
Reply Quote Save Share Report
ben_calgary
Member
245
1,123
Oct 2024
Calgary, CA
Dec 7, 2024 at 12:05 PM#52
quinn_sf said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

22 20CanadaChris, ZaraB_AL, JakeSmashed95 and 19 others
Reply Quote Save Share Report
maya_sedona
Member
289
1,234
Sep 2024
Sedona, AZ
Dec 15, 2024 at 7:01 PM#53
quinn_sf said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

True, with the qualification that this is a self-selected group. The people for whom it did not work post less, and that shapes everything we think we know.

That is the short version; the long version is somebody else's post.

Last edited: Dec 15, 2024 at 11:01 PM
23 21BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 20 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
Dec 24, 2024 at 1:53 AM#54
quinn_sf said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Taking it to my next appointment.

24 22Dr.SurgeonPGH, rachel_ABQ, traveltech_sara and 21 others
Reply Quote Save Share Report
jim_asheville
Member
289
1,234
Aug 2024
Asheville, NC
Jan 1, 2025 at 8:40 AM#55

From the other side of the consultation, briefly. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

25 23LarryQC_SD, wanda_boise, NurseAsh_DET and 22 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register